Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Jul 21;289(6438):153–156. doi: 10.1136/bmj.289.6438.153

Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation.

W R Ellis, K W Somerville, B H Whitten, G D Bell
PMCID: PMC1442019  PMID: 6430390

Abstract

Thirty patients with radiolucent stones in a radiologically functioning gall bladder were treated for up to two years with a combination of Rowachol (one capsule twice daily), a mixture of cyclic monoterpenes, and chenodeoxycholic acid (7.0-10.5 mg/kg/day). The patients were not selected for body weight or size of stones. All complete dissolutions diagnosed by oral cholecystography were confirmed or refuted by ultrasound examination. Control of symptoms was excellent, only one patient withdrawing from the study because of persistent biliary pain. No evidence of hepatotoxicity was detected biochemically, and diarrhoea due to chenodeoxycholic acid was minimal at this dose. Stones disappeared completely in 11 patients (37%) within one year and in 15 (50%) within two years. These results compared favourably with those obtained with similar doses of chenodeoxycholic acid alone, in particular those of the National Co-operative Gallstone Study (complete dissolution in 13.5% of patients at two years). Treatment with a combination of medium dose chenodeoxycholic acid with Rowachol for radiolucent gall stones is economical, effective, and likely to minimise persistent symptoms and adverse effects of treatment.

Full text

PDF
153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOETTGE K. Atherische Ole und Spasmolyse. Med Monatsschr. 1954 Jul;8(7):444–446. [PubMed] [Google Scholar]
  2. Bachrach W. H., Hofmann A. F. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I. Dig Dis Sci. 1982 Aug;27(8):737–761. doi: 10.1007/BF01393771. [DOI] [PubMed] [Google Scholar]
  3. Bateson M. C., Ross P. E., Murison J., Bouchier I. A. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution. Lancet. 1978 May 27;1(8074):1111–1114. [PubMed] [Google Scholar]
  4. Bell G. D., Whitney B., Dowling R. H. Gallstone dissolution in man using chenodeoxycholic acid. Lancet. 1972 Dec 9;2(7789):1213–1216. doi: 10.1016/s0140-6736(72)92266-0. [DOI] [PubMed] [Google Scholar]
  5. Doran J., Keighley M. R., Bell G. D. Rowachol--a possible treatment for cholesterol gallstones. Gut. 1979 Apr;20(4):312–317. doi: 10.1136/gut.20.4.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ellis W. R., Bell G. D., Middleton B., White D. A. Adjunct to bile-acid treatment for gall-stone dissolution: low-dose chenodeoxycholic acid combined with a terpene preparation. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):611–612. doi: 10.1136/bmj.282.6264.611-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gerolami A., Sarles H., Brette R., Paraf A., Rautureau J., Debray C., Bermann C., Etienne J. P., Chaput J. C., Petite J. P. Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study. Digestion. 1977;16(4):299–307. doi: 10.1159/000198082. [DOI] [PubMed] [Google Scholar]
  8. Hordinsky B. Z. Terpenes in the treatment of gallstones. Minn Med. 1971 Aug;54(8):649–652. [PubMed] [Google Scholar]
  9. Iser J. H., Maton P. N., Murphy G. M., Dowling R. H. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones. Br Med J. 1978 Jun 10;1(6126):1509–1512. doi: 10.1136/bmj.1.6126.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iser J. H., Sali A. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. Drugs. 1981 Feb;21(2):90–119. doi: 10.2165/00003495-198121020-00002. [DOI] [PubMed] [Google Scholar]
  11. Maudgal D. P., Bird R., Northfield T. C. Optimal timing of doses of chenic acid in patients with gall stones. Br Med J. 1979 Apr 7;1(6168):922–923. doi: 10.1136/bmj.1.6168.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mok H. Y., Bell G. D., Dowling R. H. Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones. Lancet. 1974 Aug 3;2(7875):253–257. doi: 10.1016/s0140-6736(74)91415-9. [DOI] [PubMed] [Google Scholar]
  13. Noda H., Kuriyama S., Tokuda A. [Clinico-pathological studies on cholelithiasis. II. Medical treatment of choleithiasis experience of therapy with terebene oil preparation]. Naika Hokan. 1965 Sep;12(9):505–511. [PubMed] [Google Scholar]
  14. Ponz de Leon M., Loria P., Carulli N., Murphy G. M., Dowling R. H. Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. Eur J Clin Invest. 1980 Aug;10(4):261–271. doi: 10.1111/j.1365-2362.1980.tb00032.x. [DOI] [PubMed] [Google Scholar]
  15. SARREITHER W. Rowachol-Cholex, ein terpenhaltiges Präparat zur Behandlung der Cholelithiasis. Med Monatsschr. 1955 Feb;9(2):97–99. [PubMed] [Google Scholar]
  16. Schoenfield L. J., Lachin J. M. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med. 1981 Sep;95(3):257–282. doi: 10.7326/0003-4819-95-3-257. [DOI] [PubMed] [Google Scholar]
  17. Shapero T. F., Rosen I. E., Wilson S. R., Fisher M. M. Discrepancy between ultrasound and oral cholecystography in the assessment of gallstone dissolution. Hepatology. 1982 Sep-Oct;2(5):587–590. doi: 10.1002/hep.1840020512. [DOI] [PubMed] [Google Scholar]
  18. Somerville K. W., Rose D. H., Bell G. D., Ellis W. R., Knapp D. R. Gall-stone dissolution and recurrence: are we being misled? Br Med J (Clin Res Ed) 1982 May 1;284(6325):1295–1297. doi: 10.1136/bmj.284.6325.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Toouli J., Jablonski P., Watts J. M. Treatment of gallstones by chenodeoxycholic acid. Med J Aust. 1980 May 17;1(10):478–479. doi: 10.5694/j.1326-5377.1980.tb135044.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES